PEPTIDES for Veterans Act
The source supplies the latest action, but no lifecycle stage.
Latest action (8 Sep 2026): Referred to the Subcommittee on Health.
What this bill does
H.R. 10212, the "PEPTIDES for Veterans Act," would direct the Secretary of Veterans Affairs to examine how peptide-based therapies might be used in caring for veterans. It first requires the Secretary to review existing federal regulations and guidance defining "peptide," establish a working definition of that term and of "peptide-based therapy" for purposes of the Act, and report to Congress within 180 days on those definitions and related research developments. After that report is submitted, the Secretary must conduct an 18-month study on the safety, efficacy, and potential benefits of peptide-based therapies for conditions such as chronic pain, mental health, and rehabilitation needs, culminating in a report with findings and a determination on whether such therapies should be offered at VA facilities.
If the Secretary determines the therapies should be offered, the bill requires establishment of a pilot program, lasting up to five years, in which veterans may voluntarily participate, subject to limitations set by the Secretary. A final report to Congress would then assess the pilot's effectiveness, identify which conditions may benefit, and provide guidance on possible broader implementation.
The bill primarily affects the Department of Veterans Affairs and veterans who receive VA medical care, particularly those interested in peptide-based treatment options. It does not itself authorize or require VA to provide such therapies broadly; it sets up a process of review, study, and potential pilot testing.
The bill was introduced by Rep. Nancy Mace on September 1, 2026, and referred to the House Committee on Veterans' Affairs. It has not yet been voted on, and would need committee consideration, House and Senate passage, and presidential signature to become law.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
8 Sep 2026
Referred to the Subcommittee on Health.
Common questions
- What does H.R. 10212 do?
- H.R. 10212, the "PEPTIDES for Veterans Act," would direct the Secretary of Veterans Affairs to examine how peptide-based therapies might be used in caring for veterans. It first requires the Secretary to review existing federal regulations and guidance defining "peptide," establish a working definition of that term and of "peptide-based therapy" for purposes of the Act, and report to Congress within 180 days on those definitions and related research developments. After that report is submitted, the Secretary must conduct an 18-month study on the safety, efficacy, and potential benefits of peptide-based therapies for conditions such as chronic pain, mental health, and rehabilitation needs, culminating in a report with findings and a determination on whether such therapies should be offered at VA facilities. If the Secretary determines the therapies should be offered, the bill requires establishment of a pilot program, lasting up to five years, in which veterans may voluntarily participate, subject to limitations set by the Secretary. A final report to Congress would then assess the pilot's effectiveness, identify which conditions may benefit, and provide guidance on possible broader implementation. The bill primarily affects the Department of Veterans Affairs and veterans who receive VA medical care, particularly those interested in peptide-based treatment options. It does not itself authorize or require VA to provide such therapies broadly; it sets up a process of review, study, and potential pilot testing. The bill was introduced by Rep. Nancy Mace on September 1, 2026, and referred to the House Committee on Veterans' Affairs. It has not yet been voted on, and would need committee consideration, House and Senate passage, and presidential signature to become law.
- Has H.R. 10212 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 10212. Check the latest action and official source below.
- Who sponsored H.R. 10212?
- H.R. 10212 was sponsored by Rep. Mace, Nancy [R-SC-1] (R-SC), with 0 cosponsors.
- What's the latest action on H.R. 10212?
- Referred to the Subcommittee on Health. (8 Sep 2026).
Related bills in Armed Forces and National Security
To authorize the Secretary of the Army to convey to the State of North Carolina a certain parcel of real property located at Fort Bragg, North Carolina, on which the State shall construct a veterans’ State home, and for other purposes.
CISA Securing AI Task Force Act
Veterans Outdoor Rehabilitation Act
To direct the Secretary of Defense to update the Critical Asset List of the Department of Defense to incorporate assets critical to the development, deployment, and operation of the Golden Dome missile defense system.
More bills from Rep. Mace, Nancy [R-SC-1]
School Freedom Act of 2026
Speak Your Truth Act
Pesticide Transparency on Federal Land Act
Pesticide Data Transparency Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.